Core Viewpoint - ST Hezhong focuses on the production and sales of outdoor (12-40.5kV) transformers, distribution, and related control equipment, with no current products for controllable nuclear fusion projects [1] Group 1: Product Offerings - The company’s product range includes ring main units, switchgear, pole-mounted switches, box-type substations, transformers, and intelligent distribution terminals [1] Group 2: Application Scenarios - Downstream application scenarios for the company’s products encompass smart grids, renewable energy construction, rail transit, commercial real estate, data centers, and petrochemicals [1]

ST合纵（300477.SZ）10月16日在投资者互动平台表示，您好！公司暂未收到大股东增持计划相关的信 息。感谢关注。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：大股东持股比例持续下降，是否有增持计划？ ...

证券代码：300477 证券简称：ST 合纵 公告编号：2025-066 合纵科技股份有限公司 关于公司股票被实施其他风险警示相关事项的进展 公告 本公司及董事会全体成员保证公告的内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 一、被实施其他风险警示暨可能被实施退市风险警示的相关情况 二、采取的措施及有关工作的进展情况 合纵科技股份有限公司（以下简称"公司"）2024 年度财务报告内部控制 被中兴财光华会计师事务所（特殊普通合伙）（以下简称"中兴财光华"）出具 了否定意见的审计报告。根据《深圳证券交易所创业板股票上市规则》第 9.4 条第（四）项规定，公司出现"（四）最近一个会计年度财务报告内部控制被出 具无法表示意见或者否定意见的审计报告，或者未按照规定披露财务报告内部控 制审计报告"的情形，公司股票交易被深圳证券交易所实施其他风险警示；根据 《深圳证券交易所创业板股票上市规则》第 10.4.4 条第（五）项规定，上市公 司出现"首个会计年度财务报告内部控制被出具无法表示意见或者否定意见的审 计报告，或者未按照规定披露财务报告内部控制审计报告"的情形，上市公司应 当立即披露股票交易可能被实施 ...

证券代码：300477 证券简称：ST 合纵 公告编号：2025-065 合纵科技股份有限公司 关于对外担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 合纵科技股份有限公司（以下简称"公司"）提供担保总额超过最近一期经 审计净资产100%，敬请投资者注意相关风险。 一、担保情况概述 公司分别于2025年4月28日、2025年5月22日召开了第七届董事会第三次会议 及2024年年度股东大会，会议审议通过了《关于2025年度向金融机构申请综合授 信额度预计及为子公司提供担保额度预计的议案》，同意公司为全资子公司湖南 赫利俄斯新能源有限公司（以下简称"赫利俄斯"）提供不超过1,000万元的连 带责任保证担保。上述额度包括已生效并正在执行的担保及原有担保的展期或续 保以及未来拟签署的担保，额度期限自公司2024年年度股东大会审议通过之日起 12个月内有效。同时，公司股东大会授权公司管理层代表公司在股东大会批准的 担保额度内办理上述担保事宜，签署相关法律文件。具体详见公司于2025年4月 29日在巨潮资讯网披露的《关于2025年度向金融机构申 ...

Core Viewpoint - The company is actively seeking solutions for future development, focusing on optimizing business structure, improving operational efficiency, and enhancing cost control to boost core competitiveness and profitability, thereby increasing market value [2]. Financial Status and Market Value Management - The company is committed to managing its market value by focusing on its core business, enhancing internal control systems, and promoting high-quality development [4]. - The company is currently exploring new financing channels while negotiating with creditors regarding over 100 million in commercial bills that are due [3]. Debt Management Strategies - The company faces a high debt ratio of 90.29% and is taking measures to optimize cash flow, reduce unnecessary expenditures, and prioritize repayment of high-interest debts to lower financial costs [5]. Operational Updates - The company is adhering to relevant regulations for information disclosure and is focused on addressing internal control deficiencies identified in the 2024 audit report [6]. - The subsidiary, Hunan Yacheng, is currently producing lithium battery precursor products and has sufficient orders for its phosphate iron products, with a balanced production and sales situation [6].

Financial Status and Debt Management - The company has a high debt ratio of 90.29%, which significantly impacts its normal operations [3][21] - The company is actively seeking solutions to improve its financial situation, including optimizing cash flow and reducing unnecessary expenses [3][5] - There are over 100 million in commercial bills due that have not been settled, which may affect business operations and future financing [2][3] Market Position and Business Strategy - The company is focusing on enhancing its core competitiveness and profitability through business structure optimization and cost control measures [2][3] - The price of phosphoric iron has seen a slight recovery, indicating a potential market rebound, which the company is optimistic about [6][21] - The company is committed to improving internal controls and governance to facilitate high-quality development [3][5] Shareholder and Investor Relations - The company is under scrutiny regarding its market value management and has plans to enhance shareholder communication [2][3] - There are ongoing discussions about potential strategic partnerships and restructuring plans, although specific details are not disclosed [4][5][21] - The company emphasizes compliance with disclosure obligations as per the Shenzhen Stock Exchange regulations [4][10] Future Outlook and Measures - The company is taking steps to address internal control deficiencies identified in the 2024 audit report and is working towards rectifying these issues [6][9] - Efforts are being made to improve cash flow and manage short-term debt pressures, with a focus on timely collection of receivables [6][21] - The company is exploring new financing channels to support its operations and growth [3][5]

合纵科技股份有限公司 关于参加 2025 年湖南辖区上市公司投资者网上集体 接待日暨半年度业绩说明会活动的公告 本公司及董事会全体成员保证公告的内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 为进一步加强与投资者的互动交流，合纵科技股份有限公司（以下简称"公 司"）将参加由湖南证监局、湖南省上市公司协会与深圳市全景网络有限公司联 合举办的"资本聚三湘 楚光耀新程——2025 年湖南辖区上市公司投资者网上 集体接待日暨半年度业绩说明会"活动，现将相关事项公告如下： 证券代码：300477 证券简称：ST 合纵 公告编号：2025-064 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP， 参与本次互动交流，活动时间为 2025 年 9 月 19 日（星期五）14：00-17：00。 届时，公司高管将在线就公司 2024 年至 2025 半年度业绩、公司治理、发展战略、 经营状况、融资计划、股权激励和可持续发展等投资者关心的问题，与投资者进 行沟通与交流，欢迎广大投资者踊跃参与！ 特此公告。 ...

Group 1 - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% of the company's total shares, amounting to approximately 174 million shares [1] - Jinlongyu's shareholder terminates the share transfer agreement, halting the planned transfer of 5.32% of the company's shares [1] - Doli Technology's subsidiary plans to establish a joint venture in Spain with an investment of approximately 505 million yuan, with a 70% stake held by Doli Technology [1][2] Group 2 - Chongqing Pharmaceutical, a subsidiary of Zhongyao Holdings, has received approval for clinical trials of its drug, Clopidogrel Hydrochloride Tablets [3][4] - Dongyangguang plans to jointly increase capital in a subsidiary to acquire 100% of Qinhuai Data China for 28 billion yuan [5] - Kangzhi Pharmaceutical's controlling shareholder intends to transfer 5.0004% of the company's shares at a price of 5.34 yuan per share, totaling approximately 122 million yuan [6] Group 3 - Huali Co., Ltd. announces two shareholders plan to reduce their stakes by a combined total of up to 3.96% of the company's shares [7] - Fangbang Co., Ltd.'s director plans to reduce his stake by up to 15,000 shares, representing 0.1844% of the total shares [8] - China Pacific Insurance suggests issuing HKD-denominated convertible bonds, with proceeds aimed at supporting its main insurance business and strategic initiatives [9] Group 4 - Microchip Biotech's shareholder plans to reduce its stake by up to 3% of the company's total shares [10] - Hongbai New Materials' controlling shareholder intends to reduce its stake by up to 3% due to funding needs [11] - Zhejiang Rongtai clarifies that its sales in the robotics components sector are minimal and will not significantly impact annual net profit [12] Group 5 - ST Tianmao voluntarily withdraws its application for A-share listing, which has been accepted by the Shenzhen Stock Exchange [13] - Qingxin Environment's shareholder plans to reduce its stake by up to 1% of the company's total shares [14] - Lanjik Technology's two shareholders plan to reduce their stakes by a combined total of up to 2% of the company's shares [15] Group 6 - BYD's executives and core personnel collectively increased their holdings in the company by approximately 52.33 million yuan [16] - Trina Solar's subsidiary signs contracts for the sale of 2.48 GWh of energy storage products, marking a significant overseas order [17] - Chutianlong's shareholder plans to reduce its stake by up to 3% of the company's total shares [18] Group 7 - Zhongjuxin's shareholder plans to reduce its stake by up to 2.5% of the company's total shares due to funding needs [19] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [20] - Shoukai Co., Ltd. reports a signed contract amount of 973 million yuan for August, with cumulative contracts of 13.15 billion yuan for the year [21] Group 8 - Jucheng Co., Ltd.'s shareholder plans to reduce its stake by up to 2.61% of the company's total shares due to personal funding needs [22]

Group 1 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of 100% equity in Qinhuai Data China, with a total investment of 75 billion yuan [2] - Baiyin Nonferrous Metals is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [3] - Beida Pharmaceutical intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [5] Group 2 - ST Tianmao plans to withdraw its A-share listing and transfer to the National SME Share Transfer System after delisting [5] - Goldwind Technology has approved an investment agreement for a 3GW wind-hydrogen-ammonia integration project in Inner Mongolia, with a total investment of approximately 189.2 billion yuan [6] - Langzi Co. has signed an agreement to acquire 67.5% of Chongqing Milan Baiyu Shiguang Medical Beauty Hospital for 92.475 million yuan [7] Group 3 - Dongfang Guoxin is establishing a joint venture with Beijing Shunyi Financial Holdings to focus on computing power infrastructure and services, with a registered capital of 300 million yuan [8] - ST Hezhong's chairman is under bail pending trial, but the company's operations remain unaffected [9] - Kangzhi Pharmaceutical's major shareholder is transferring 22.758 million shares at a price of 5.34 yuan per share, totaling 122 million yuan [9] Group 4 - Shenzhen Airport reported a passenger throughput of 5.807 million in August, a year-on-year increase of 4.07% [10] - Lin Yang Energy won a bid for a project with a total amount of approximately 244.08 million yuan [11] - Fullpower New Materials received a government subsidy of 20 million yuan, which is expected to positively impact its 2025 profits [14] Group 5 - BYD executives and core personnel collectively increased their holdings by 48.82 million shares, totaling 52.3278 million yuan [16] - Hualing Steel's major shareholder increased its stake by 6.90862 million shares, representing a 1% increase in ownership [16]

Core Points - ST HZ's controlling shareholder and chairman Liu Zegang has been granted a bail decision by the Chaoyang Public Security Bureau, allowing him to perform his duties normally, with no impact on the company's daily operations [1] - The company faced a fine of 9.5 million yuan due to violations in information disclosure related to financial assistance provided to related parties, amounting to 508 million yuan, which constituted significant omissions [1][2] - In 2023, ST HZ reported a net loss of 643 million yuan, a year-on-year decline of 9044.38%, and received a qualified opinion from the auditing firm due to undisclosed related party relationships and significant deficiencies in internal controls [3] Financial and Operational Summary - As of June 30, 2025, ST HZ's current assets were 1.779 billion yuan, while current liabilities reached 3.641 billion yuan, resulting in a liquidity shortfall of 1.862 billion yuan [3] - The company's debt ratio stood at 90.29%, indicating significant repayment pressure [3] - ST HZ and its subsidiary Tianjin New Energy were listed on the overdue bill list, with a total overdue commercial acceptance bill balance of 157 million yuan, representing 14% of the company's latest audited net assets [4]